182 related articles for article (PubMed ID: 10615944)
1. Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit.
Maddux BA; Goldfine ID
Diabetes; 2000 Jan; 49(1):13-9. PubMed ID: 10615944
[TBL] [Abstract][Full Text] [Related]
2. The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121).
Costanzo BV; Trischitta V; Di Paola R; Spampinato D; Pizzuti A; Vigneri R; Frittitta L
Diabetes; 2001 Apr; 50(4):831-6. PubMed ID: 11289049
[TBL] [Abstract][Full Text] [Related]
3. Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects: evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling.
Frittitta L; Spampinato D; Solini A; Nosadini R; Goldfine ID; Vigneri R; Trischitta V
Diabetes; 1998 Jul; 47(7):1095-100. PubMed ID: 9648833
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of membrane glycoprotein PC-1 can influence insulin action at a post-receptor site.
Kumakura S; Maddux BA; Sung CK
J Cell Biochem; 1998 Mar; 68(3):366-77. PubMed ID: 9518262
[TBL] [Abstract][Full Text] [Related]
5. Expression of the putative inhibitor of the insulin receptor tyrosine kinase PC-1 in dermal fibroblasts from patients with syndromes of severe insulin resistance.
Whitehead JP; Humphreys PJ; Dib K; Goding JW; O'Rahilly S
Clin Endocrinol (Oxf); 1997 Jul; 47(1):65-70. PubMed ID: 9302374
[TBL] [Abstract][Full Text] [Related]
6. Membrane glycoprotein PC-1 and insulin resistance.
Goldfine ID; Maddux BA; Youngren JF; Frittitta L; Trischitta V; Dohm GL
Mol Cell Biochem; 1998 May; 182(1-2):177-84. PubMed ID: 9609127
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity.
Belfiore A; Costantino A; Frasca F; Pandini G; Mineo R; Vigneri P; Maddux B; Goldfine ID; Vigneri R
Mol Endocrinol; 1996 Nov; 10(11):1318-26. PubMed ID: 8923458
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma cell membrane glycoprotein levels and diminished insulin receptor autophosphorylation in obese, insulin-resistant rhesus monkeys.
Pender C; Ortmeyer HK; Hansen BC; Goldfine ID; Youngren JF
Metabolism; 2002 Apr; 51(4):465-70. PubMed ID: 11912555
[TBL] [Abstract][Full Text] [Related]
9. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus.
Maddux BA; Sbraccia P; Kumakura S; Sasson S; Youngren J; Fisher A; Spencer S; Grupe A; Henzel W; Stewart TA
Nature; 1995 Feb; 373(6513):448-51. PubMed ID: 7830796
[TBL] [Abstract][Full Text] [Related]
10. Role of PC-1 in the etiology of insulin resistance.
Goldfine ID; Maddux BA; Youngren JF; Trischitta V; Frittitta L
Ann N Y Acad Sci; 1999 Nov; 892():204-22. PubMed ID: 10842664
[TBL] [Abstract][Full Text] [Related]
11. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.
Goldfine ID; Maddux BA; Youngren JF; Reaven G; Accili D; Trischitta V; Vigneri R; Frittitta L
Endocr Rev; 2008 Feb; 29(1):62-75. PubMed ID: 18199690
[TBL] [Abstract][Full Text] [Related]
12. Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity.
Chin CN; Dallas-Yang Q; Liu F; Ho T; Ellsworth K; Fischer P; Natasha T; Ireland C; Lu P; Li C; Wang IM; Strohl W; Berger JP; An Z; Zhang BB; Jiang G
Eur J Pharmacol; 2009 Mar; 606(1-3):17-24. PubMed ID: 19374858
[TBL] [Abstract][Full Text] [Related]
13. Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM.
Shao J; Catalano PM; Yamashita H; Ruyter I; Smith S; Youngren J; Friedman JE
Diabetes; 2000 Apr; 49(4):603-10. PubMed ID: 10871198
[TBL] [Abstract][Full Text] [Related]
14. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.
Sakoda H; Ogihara T; Anai M; Funaki M; Inukai K; Katagiri H; Fukushima Y; Onishi Y; Ono H; Yazaki Y; Kikuchi M; Oka Y; Asano T
Diabetes; 1999 Jul; 48(7):1365-71. PubMed ID: 10389840
[TBL] [Abstract][Full Text] [Related]
15. Increased activity of membrane glycoprotein PC-1 in the fibroblasts from non-insulin-dependent diabetes mellitus patients with insulin resistance.
Teno S; Kanno H; Oga S; Kumakura S; Kanamuro R; Iwamoto Y
Diabetes Res Clin Pract; 1999 Aug; 45(1):25-30. PubMed ID: 10499882
[TBL] [Abstract][Full Text] [Related]
16. The development of insulin resistance with high fat feeding in rats does not involve either decreased insulin receptor tyrosine kinase activity or membrane glycoprotein PC-1.
Ozel B; Youngren JF; Kim JK; Goldfine ID; Sung CK; Youn JH
Biochem Mol Med; 1996 Dec; 59(2):174-81. PubMed ID: 8986641
[TBL] [Abstract][Full Text] [Related]
17. Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-alpha gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity.
Frittitta L; Youngren JF; Sbraccia P; D'Adamo M; Buongiorno A; Vigneri R; Goldfine ID; Trischitta V
Diabetologia; 1997 Mar; 40(3):282-9. PubMed ID: 9084965
[TBL] [Abstract][Full Text] [Related]
18. PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity.
Frittitta L; Youngren J; Vigneri R; Maddux BA; Trischitta V; Goldfine ID
Diabetologia; 1996 Oct; 39(10):1190-5. PubMed ID: 8897006
[TBL] [Abstract][Full Text] [Related]
19. Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo.
Zhou HH; Chin CN; Wu M; Ni W; Quan S; Liu F; Dallas-Yang Q; Ellsworth K; Ho T; Zhang A; Natasha T; Li J; Chapman K; Strohl W; Li C; Wang IM; Berger J; An Z; Zhang BB; Jiang G
Eur J Pharmacol; 2009 Aug; 616(1-3):346-52. PubMed ID: 19577557
[TBL] [Abstract][Full Text] [Related]
20. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
Band CJ; Posner BI; Dumas V; Contreres JO
Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
